A detailed history of Gamma Investing LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 1,041 shares of CRL stock, worth $193,927. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,041
Previous 849 22.61%
Holding current value
$193,927
Previous $175 Million 16.91%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$187.96 - $245.29 $36,088 - $47,095
192 Added 22.61%
1,041 $205 Million
Q2 2024

Jul 02, 2024

BUY
$206.39 - $268.73 $85,032 - $110,716
412 Added 94.28%
849 $175 Million
Q1 2024

Apr 05, 2024

BUY
$203.52 - $273.43 $30,731 - $41,287
151 Added 52.8%
437 $118 Million
Q4 2023

Feb 01, 2024

BUY
$164.52 - $238.84 $47,052 - $68,308
286 New
286 $61.9 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.